IXICO PLC operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares IXICO PLC with three other
companies in this sector in the United Kingdom:
Puretech Health Plc
sales of £3.30 million [US$4.45 million]
of which 92%
was Growth stage operating companies),
Avacta Group Plc
(£2.17 million [US$2.92 million]
of which 67%
was Animal Health), and
Proteome Sciences PLC
(£2.74 million [US$3.70 million]
IXICO PLC reported sales of £3.11 million (US$4.20 million)
September of 2016.
decrease of 0.1%
versus 2015, when the company's sales were £3.12 million.